LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

LAVA Therapeutics NV
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LAVA Therapeutics NV
Gross Profit Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
MRUS

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Gross Profit
$3.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Gross Profit
$245.8m
CAGR 3-Years
-7%
CAGR 5-Years
6%
CAGR 10-Years
58%
ProQR Therapeutics NV
NASDAQ:PRQR
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Gross Profit
$2m
CAGR 3-Years
-83%
CAGR 5-Years
N/A
CAGR 10-Years
-7%
argenx SE
XBRU:ARGX
Gross Profit
$1.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Gross Profit?
Gross Profit
3.3m USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Gross Profit amounts to 3.3m USD.

Back to Top